Enanta Pharmaceuticals earnings were -$104.9M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest ENTA earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$22.3M, down 22.7% from last quarter. For the last reported fiscal year 2024 ending Sep 30, 2024, ENTA reported annual earnings of -$116.0M, with -13.3% growth. The next ENTA earnings date is May 5, 2025.
Enanta Pharmaceuticals Earnings Reports & History FAQ
What were Enanta Pharmaceuticals's earnings last quarter?
On ENTA's earnings call on Invalid Date, Enanta Pharmaceuticals (NASDAQ: ENTA) reported Q4 2024 earnings per share (EPS) of -$1.05, up 33.54% year over year. Total ENTA earnings for the quarter were -$22.29 million. In the same quarter last year, Enanta Pharmaceuticals's earnings per share (EPS) was -$1.58.
The next ENTA earnings call is Invalid Date. Add ENTA to your watchlist to be reminded of Enanta Pharmaceuticals's next earnings date.
What was ENTA's earnings growth in the past year?
As of Enanta Pharmaceuticals's earnings date in Invalid Date, Enanta Pharmaceuticals's earnings has grown year over year. ENTA earnings in the past year totalled -$104.93 million.
Is Enanta Pharmaceuticals profitable or losing money?
As of the last Enanta Pharmaceuticals earnings report, Enanta Pharmaceuticals is currently losing money. Enanta Pharmaceuticals's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$104.93 million, a 24.1% decrease year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.